Danaher Corporation has announced a collaboration with AstraZeneca for diagnostic tools and tests development and ...

The global immunohistochemistry (IHC) market is experiencing steady growth, with a compound annual growth rate (CAGR) of ...

This study presents an important finding on the role of GATA4 in aging and OA-associated cartilage pathology. The evidence supporting the conclusions is compelling, with rigorous in vitro and in vivo ...

Shift Bioscience, a Cambridge-based biotech company using an AI powered virtual cell to fight age-driven diseases, has strengthened its therapeutic pipeline with two new appointments.

The Cambridge Biomedical Campus – already the largest centre of medical research and health science in Europe – could double ...

This study identifies 53BP1 as an interaction partner of GMCL1 (a likely CUL3 substrate receptor). The study seeks to link this finding to regulation of the mitotic surveillance pathway and paclitaxel ...

Cambridge was recently ranked as the world’s leading science and technology cluster by intensity, with a rich spin out ecosystem from the University of Cambridge – the birthplace of UK tech success ...

Danaher Corporation DHR has been benefiting from strength in its bioprocessing business, driven by an increase in demand for consumables from large pharmaceutical customers in North America, Europe ...

North America, especially the U.S. market, continues to lead in multiplex assay adoption, driven by advanced healthcare infrastructure, while Asia-Pacific emerges as the fastest-growing region.Austin, ...

Protein quantification is an indispensable step in a wide range of biochemical and molecular biology applications. Hence, it ...

Victoria-Yang-Abcam doesn't have any public repositories yet. Something went wrong, please refresh the page to try again. If the problem persists, check the GitHub status page or contact support .